Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Japan
/
Healthcare
/
Terumo
4543
Terumo
Aging Populations And Minimally Invasive Focus Will Expand Healthcare Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 15 Analysts
Published
06 Jun 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
JP¥3,950.41
30.8% undervalued
intrinsic discount
08 Aug
JP¥2,735.50
Loading
1Y
0.6%
7D
7.3%
Author's Valuation
JP¥4.0k
30.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
JP¥4.0k
30.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
1t
2014
2017
2020
2023
2025
2026
2028
Revenue JP¥1.3t
Earnings JP¥194.7b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.79%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.62%
Calculation
JP¥194.74b
Earnings '28
x
34.54x
PE Ratio '28
=
JP¥6.73t
Market Cap '28
JP¥6.73t
Market Cap '28
/
1.45b
No. shares '28
=
JP¥4.65k
Share Price '28
JP¥4.65k
Share Price '28
Discounted to 2025 @ 5.62% p.a.
=
JP¥3.95k
Fair Value '25